Cargando…

Complement, a Therapeutic Target in Diabetic Kidney Disease

Currently available treatments of diabetic kidney disease (DKD) remain limited despite improved understanding of DKD pathophysiology. The complement system is a central part of innate immunity, but its dysregulated activation is detrimental and results in systemic diseases with overt inflammation. G...

Descripción completa

Detalles Bibliográficos
Autores principales:	Budge, Kelly, Dellepiane, Sergio, Yu, Samuel Mon-Wei, Cravedi, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7858668/ https://www.ncbi.nlm.nih.gov/pubmed/33553201 http://dx.doi.org/10.3389/fmed.2020.599236

Ejemplares similares

Complement in Non-Antibody-Mediated Kidney Diseases
por: Angeletti, Andrea, et al.
Publicado: (2017)

T Cells and Acute Kidney Injury: A Two-Way Relationship
por: Dellepiane, Sergio, et al.
Publicado: (2020)

Complement and Complement Targeting Therapies in Glomerular Diseases
por: Andrighetto, Sofia, et al.
Publicado: (2019)

Complement in Lupus: Biomarker, Therapeutic Target, or a Little Bit of Both?
por: Cantarelli, Chiara, et al.
Publicado: (2021)

Management of Chronic Hyperkalemia in Patients With Chronic Kidney Disease: An Old Problem With News Options
por: Morales, Enrique, et al.
Publicado: (2021)

Proteinuric Kidney Diseases: A Podocyte's Slit Diaphragm and Cytoskeleton Approach
por: Yu, Samuel Mon-Wei, et al.
Publicado: (2018)

Complement in Kidney Transplantation
por: Cernoch, Marek, et al.
Publicado: (2017)

Editorial: Role of complement activation in kidney diseases
por: Oda, Takashi, et al.
Publicado: (2023)

COVID-19 and the Kidneys: An Update
por: Benedetti, Claudia, et al.
Publicado: (2020)

Therapeutic Potential of Targeting Complement C5a Receptors in Diabetic Kidney Disease
por: Trambas, Inez A., et al.
Publicado: (2023)

Circular RNAs as Novel Diagnostic Biomarkers and Therapeutic Targets in Kidney Disease
por: Yu, Jianwen, et al.
Publicado: (2021)

Activation of Complement Pathways in Kidney Tissue May Mediate Tubulointerstitial Injury in Diabetic Nephropathy
por: Jiang, Shimin, et al.
Publicado: (2022)

Potential Involvement of Complement Activation in Kidney Vascular Lesions of Arterionephrosclerosis
por: Chen, Xuejing, et al.
Publicado: (2022)

Decay-Accelerating Factor Restrains Complement Activation and Delays Progression of Murine cBSA-Induced Membranous Nephropathy
por: Budge, Kelly L, et al.
Publicado: (2023)

Inflammatory Cytokines in Diabetic Kidney Disease: Pathophysiologic and Therapeutic Implications
por: Donate-Correa, Javier, et al.
Publicado: (2021)

Clinicopathologic Implications of Complement Genetic Variants in Kidney Transplantation
por: Ren, Zhen, et al.
Publicado: (2021)

Increased Complement Gene Expression in Circulating B Cells From Kidney Transplant Recipients With Chronic Antibody-Mediated Rejection
por: Cravedi, Paolo, et al.
Publicado: (2022)

Therapeutic Insights in Chronic Kidney Disease Progression
por: Shabaka, Amir, et al.
Publicado: (2021)

Immune-Monitoring Disease Activity in Primary Membranous Nephropathy
por: Cravedi, Paolo, et al.
Publicado: (2019)

HCV-Associated Nephropathies in the Era of Direct Acting Antiviral Agents
por: Angeletti, Andrea, et al.
Publicado: (2019)

Complement in neurological disorders and emerging complement-targeted therapeutics
por: Dalakas, Marinos C., et al.
Publicado: (2020)

Report of Three Cases of Minimal Change Disease Following the Second Dose of mRNA SARS-CoV-2 COVID-19 Vaccine
por: Salem, Fadi, et al.
Publicado: (2021)

NAD(+) Homeostasis in Diabetic Kidney Disease
por: Xu, Jing, et al.
Publicado: (2021)

Mitochondrial Regulation of Diabetic Kidney Disease
por: Galvan, Daniel L., et al.
Publicado: (2021)

Protein Methylation in Diabetic Kidney Disease
por: Cheng, Ye, et al.
Publicado: (2022)

Complement as a Therapeutic Target in Systemic Autoimmune Diseases
por: Galindo-Izquierdo, María, et al.
Publicado: (2021)

Diabetic Kidney Disease: Pathophysiology and Therapeutic Targets
por: Toth-Manikowski, Stephanie, et al.
Publicado: (2015)

Association between serum complements and kidney function in patients with diabetic kidney disease
por: Liu, Meng-chao, et al.
Publicado: (2023)

Detrimental cross-talk between sepsis and acute kidney injury: new pathogenic mechanisms, early biomarkers and targeted therapies
por: Dellepiane, Sergio, et al.
Publicado: (2016)

Complement System in Dermatological Diseases – Fire Under the Skin
por: Panelius, Jaana, et al.
Publicado: (2015)

Novel Therapeutic Target(s) for Psoriatic Disease
por: Thakur, Vishal, et al.
Publicado: (2022)

Non-Coding RNAs as Biomarkers and Therapeutic Targets for Diabetic Kidney Disease
por: Gu, Yue-Yu, et al.
Publicado: (2021)

Polyphosphates and Complement Activation
por: Conway, Edward M.
Publicado: (2019)

Complementing Tissue Testing With Plasma Mutation Profiling Improves Therapeutic Decision-Making for Patients With Lung Cancer
por: Choudhury, Yukti, et al.
Publicado: (2022)

Editorial: Next Therapeutic Targets in Ocular Diseases
por: Yanai, Ryoji, et al.
Publicado: (2022)

Editorial: Cell Cross-talk in Diabetic Kidney Diseases
por: Hong, Quan, et al.
Publicado: (2022)

Complement Levels at Admission Reflecting Progression to Severe Acute Kidney Injury (AKI) in Coronavirus Disease 2019 (COVID-19): A Multicenter Prospective Cohort Study
por: Henry, Brandon M., et al.
Publicado: (2022)

AMPK and Polycystic Kidney Disease Drug Development: An Interesting Off-Target Target
por: Caplan, Michael J.
Publicado: (2022)

Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics
por: Garred, Peter, et al.
Publicado: (2021)

Role of Complement and Histones in Sepsis
por: Zetoune, Firas S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rbvrdt6dd63i3rk1e69v5nbbvc